Send feedback

ACVR2B p.Glu347=

c.1041G>A · VCV4699308

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
ultra-rare (popmax 0.0213%, afr)
Conditions
1
heterotaxy, visceral, 4, autosomal

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 8.5GERP 1, phastCons 1
Overall
CADD12.5PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0213% African / African-American · 16/74,944 alleles
Filtering AF 0.0133% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0109%
Overall 0.00124% 20/1,614,114 alleles · ultra-rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.0213% 4,684
Admixed American 0.00667% 15,003

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ACVR2B
Protein
p.Glu347=
Coding
c.1041G>A
MANE Select
NM_001106
Type
single nucleotide variant
Location
chr3:38481432 (GRCh38)
Gene constraint
LOEUF 0.408 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 84.18 · 9 PDB
Residue 347
the protein kinase domain
Full ACVR2B gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/acvr2b-p-glu347 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown